GLS-1200 Topical Nasal Spray to Prevent Sinusitis After Endoscopic Sinus Surgery

NCT04060316 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Sinusitis Chronic

Interventions

DRUG: GLS-1200
DRUG: Placebo

Sponsor

GeneOne Life Science, Inc.